AbCellera to Present at Upcoming Investor Conferences in November
AbCellera (Nasdaq: ABCL) announced participation in two major investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
-
Credit Suisse 31st Annual Healthcare Conference on
Wednesday, November 9, 2022 , at3:50 p.m. Pacific Time (6:50 p.m. Eastern Time ) -
Stifel 2022 Healthcare Conference on
Tuesday, November 15, 2022 , at8:30 a.m. Pacific Time (11:30 a.m. Eastern Time )
Live audio webcasts of each presentation may be accessed through links that will be posted on AbCellera's Investor Relations website. Replays of each webcast will be available through the same links following the presentations.
About
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.
Source:
View source version on businesswire.com: https://www.businesswire.com/news/home/20221104005586/en/
Inquiries
Media:
Business Development:
Investor Relations:
Source: